MARKET

AXGN

AXGN

Axogen Inc
NASDAQ
40.90
-0.41
-0.99%
After Hours: 40.23 -0.67 -1.64% 17:38 05/22 EDT
OPEN
41.70
PREV CLOSE
41.31
HIGH
41.72
LOW
40.75
VOLUME
515.57K
TURNOVER
--
52 WEEK HIGH
45.83
52 WEEK LOW
9.22
MARKET CAP
2.17B
P/E (TTM)
-64.2981
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AXGN last week (0511-0515)?
Weekly Report · 5d ago
AxoGen Director Makes Notable Insider Move With Fresh Stock Sale
TipRanks · 05/13 02:12
Axogen director Amy McBride-Wendell disposes 1,647 shares worth $70,162.2
PUBT · 05/12 20:07
Weekly Report: what happened at AXGN last week (0504-0508)?
Weekly Report · 05/11 09:21
AxoGen Insiders Quietly Unload a Wave of Shares in Major Cash-Out Spree
TipRanks · 05/09 02:05
Axogen director John Johnson disposes of 11,050 shares worth $478,966.75
PUBT · 05/08 20:10
Axogen director Kathy Johnson Weiler disposes 16,344 shares for $720,448.7
PUBT · 05/08 20:10
Axogen CMO Jens Kemp disposes 4,000 shares worth $173,761.20
PUBT · 05/08 20:09
More
About AXGN
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel.

Webull offers AxoGen Inc stock information, including NASDAQ: AXGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AXGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AXGN stock methods without spending real money on the virtual paper trading platform.